Tamoxifen in the treatment of metastatic malignant melanoma: still a controversy? (Review).

International journal of oncology

Volumn 15, Issue 2, 1999, Pages 321-337

  Toma, S ^a   Ugolini, D ^a   Palumbo, R ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TAMOXIFEN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; MELANOMA; METASTASIS; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANTINEOPLASTIC AGENTS, HORMONAL; CLINICAL TRIALS, PHASE II; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MELANOMA; RANDOMIZED CONTROLLED TRIALS; TAMOXIFEN;

MLCS; MLOWN;

EID: 0033174416     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.15.2.321     Document Type: Review

References (87)